Research Report on the Chinese Small Molecule Targeted Drug Market (Part 1)

Based on research into the Chinese small molecule targeted drug market, Frost & Sullivan has released a series of research reports on the market. The first part of the report focuses on three aspects: anti-vascular small molecule targeted drugs, ALK/ROS1 small molecule targeted drugs, and JAK inhibitor drugs. It includes the mechanism of action of the drugs, the epidemiology of target indications, the current medication status for related diseases, the competitive landscape at clinical stages for similar drugs, and Frost & Sullivan's historical statistics and future forecasts on the market size of this segment.